• The Consolidated Drug Channel and Cash-Pay Drugs

  • Nov 3 2022
  • Duración: 36 m
  • Podcast

The Consolidated Drug Channel and Cash-Pay Drugs

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • What’s up with the drug channel? Julie Yoo, a general partner at a16z Bio+Health, joins Adam Fein, the CEO of Drug Channels Institute, and Olivia Webb, the editorial lead for a16z Bio+Health, to discuss this question. We talk about PBMs, the 340B drug program, some of the startups working within and around the primary drug channel, and whether there’s room for entrepreneurs to build in such a consolidated space.

    For additional reading, see some of Adam’s work on his blog, Drug Channels:

    • https://www.drugchannels.net/2022/08/the-340b-program-climbed-to-44-billion.html
    • https://www.drugchannels.net/2022/04/the-top-pharmacy-benefit-managers-of.html
    • https://www.drugchannels.net/2020/05/insurers-pbms-specialty-pharmacies.html
    • https://www.drugchannels.net/2020/08/how-goodrx-profits-from-our-broken.html
    • https://www.drugchannels.net/2022/10/five-surprising-facts-about-goodrx-and.html
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre The Consolidated Drug Channel and Cash-Pay Drugs

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles